Search for 'Provider:Investigational new drugs,'

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.

By Sepúlveda Sánchez, Juan Manuel. Investigational new drugs, 2015 . 33(2):357-70. , Formato Vancouver: Rodón J, Carducci M, Sepulveda Sánchez JM, Azaro A, Calvo E, Seoane J et al. Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer. Invest New Drugs. 2015 Apr;33(2):357-70.

Place Hold on Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.

A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer.

By Gómez Martín, Carlos | Núñez Sobrino, Juan Antonio. Investigational new drugs, 2013 . 31(2):390-8. , Formato Vancouver: Gómez-Martín C, Salazar R, Montagut C, Gil-Martín M, Núñez JA, Puig M et al. A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer. Invest New Drugs. 2013 Apr;31(2):390-8.

Place Hold on A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer.

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.

By Ciruelos Gil, Eva María | Cortés-Funes Castro, Hernán | Paz-Ares Rodríguez, Luis. Investigational New Drugs, 2012 . 30(2):729-40. , Formato Vancouver: Paz-Ares L, López-Pousa A, Poveda A, Balañá C, Ciruelos E, Bellmunt J, et al. Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone. Invest New Drugs. 2012 Apr;30(2):729-40.

Place Hold on Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.